Evidence map›Paper›PMID 28773721›Full record

ReviewMaterials (Basel, Switzerland)2016

Recent Developments in Antimicrobial Polymers: A Review.

Madson R E Santos, Ana C Fonseca, Patrícia V Mendonça, Rita Branco, Arménio C Serra, Paula V Morais, Jorge F J Coelho

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. PreclinicalFrontiers in bioengineering and biotechnology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Madson R E SantosCEMUC, Department of Chemical Engineering, University of Coimbra, Coimbra 3030-790, Portugal. madhsonricardo@gmail.com.
Ana C FonsecaCEMUC, Department of Chemical Engineering, University of Coimbra, Coimbra 3030-790, Portugal. ana.clo.fonseca@gmail.com.
Patrícia V MendonçaCEMUC, Department of Chemical Engineering, University of Coimbra, Coimbra 3030-790, Portugal. patmend@gmail.com.
Rita BrancoCEMUC, Department of Life Sciences, University of Coimbra, Coimbra 3001-401, Portugal. rsrbranco@gmail.com.
Arménio C SerraCEMUC, Department of Chemical Engineering, University of Coimbra, Coimbra 3030-790, Portugal. armenio.serra@gmail.com.
Paula V MoraisCEMUC, Department of Life Sciences, University of Coimbra, Coimbra 3001-401, Portugal. pvmorais@ci.uc.pt.
Jorge F J CoelhoCEMUC, Department of Chemical Engineering, University of Coimbra, Coimbra 3030-790, Portugal. jcoelho@eq.uc.pt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial polymers represent a very promising class of therapeutics with unique characteristics for fighting microbial infections. As the classic antibiotics exhibit an increasingly low capacity to effectively act on microorganisms, new solutions must be developed. The importance of this class of materials emerged from the uncontrolled use of antibiotics, which led to the advent of multidrug-resistant microbes, being nowadays one of the most serious public health problems. This review presents a critical discussion of the latest developments involving the use of different classes of antimicrobial polymers. The synthesis pathways used to afford macromolecules with antimicrobial properties, as well as the relationship between the structure and performance of these materials are discussed.

Indexed as

antimicrobial polymersbiocide polymersmultidrug resistant microbes

Identifiers

PMID28773721
PMCPMC5456892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.